Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 15, 2007 (Vol. 27, No. 4)

Current Science and Technology Podcasts

URL:www.mos.org/events_activities/podcasts
  • Wide selection of offerings
  • Nothing significant
I’m a big iPod user, so I’ll probably buy one of the first iPhones when they come out, but I must confess to not downloading too many podcasts. Don’t get me wrong, I think this format is a great idea. I am just more of a reader than a listener when it comes to scientific information. Podcasts, however, are catching the world by storm, both in audio and video formats, and the scientific world is warming to them, with virtually every major publisher providing audio in that format or planning to do so. A broad source of scientific podcasts can be found in the Current Science and Technology Podcasts site. Where other publications provide material focused on the discipline(s) in their written journals, this site spans a wide spectrum of science, including Health/Biology, Earth/Space, Tech/Engineering, Nanotech/Nanomedicine, and Events/Presentations. There’s also a section of videocasts.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »